Oracle sells $7B in debt to fund Cerner deal; Fitch downgrades credit rating

Oracle has sold $7 billion in debt to fund its purchase of Cerner, Bloomberg reported Nov. 7, after which Fitch Ratings downgraded the company’s credit rating.

Advertisement

The tech company sold the bonds in as many as four parts, a person familiar with the matter told the news outlet. The Cerner deal was financed with roughly $15.7 billion in bridge loan debt, which was later reduced when Oracle borrowed about $4.4 billion through a term-loan agreement.

Fitch subsequently lowered Oracle’s long-term issuer default rate and unsecured debt from BBB+ to BBB. The company’s rating outlook is negative, according to Fitch.

“Today’s Oracle deal has been anticipated for months, and we expect healthy participation from the buyside even though it’s a company that has been remarkably inattentive to maintaining its credit rating profile,” Baylor Lancaster-Samuel, vice president of fixed income at Amerant Investments, emailed Bloomberg. “As recently as 2020, Oracle was rated high A and with the Cerner deal, there was some threat that Oracle could flirt with a BBB- rating at the lowest rung of investment grade.”

Three credit rating agencies warned in December that they planned to possibly downgrade the company’s investment-grade ratings if it used debt to finance its $28.4 billion takeover of Cerner.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in EHRs / Interoperability

Advertisement

Comments are closed.